ENSG — The Ensign Group, Inc.

Summary of Ensign Group, Inc. Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• GAAP Diluted EPS: $1.67, up 21.9% year-over-year.
• Adjusted Diluted EPS: $1.85, up 21.7%.
• Total Revenue: $1.4 billion, an increase of 18.4%.
• GAAP Net Income: $99.7 million, up 24.2%.
• Adjusted Net Income: $110.2 million, up 23.9%.
• Cash and Cash Equivalents: $539.5 million.
• Cash Flow from Operations: $100.2 million.
• Lease Adjusted Net Debt-to-EBITDA Ratio: 1.73x.
• Quarterly Cash Dividend: $0.065 per share, marking 23 consecutive years of dividend increases.

2. Strategic Updates and Business Highlights

• Occupancy Rates: Same-store occupancy reached 84.3%, with transitioning occupancy at 85.1%.
• Skilled Revenue Growth: Same-store skilled revenue increased by 9.6% year-over-year, with Medicare revenue up 9.8%.
• Acquisitions: 22 new operations added in Q1, including 21 real estate assets, bringing total acquisitions since 2024 to 99. This includes 2,662 new skilled nursing beds.
• Clinical Excellence: 85% of operations rated 4 or 5 stars, outperforming peers significantly in quality measures.
• Labor Management: Improvements in turnover rates, particularly among directors of nursing, and reduced reliance on agency staffing.
• Standard Bearer Healthcare REIT: Generated $36.1 million in rental revenue, with a 2.7x EBITDAR to rent coverage ratio.

3. Forward Guidance and Outlook

• Earnings Guidance for 2026: Increased to $7.48 - $7.62 per diluted share, up from $7.41 - $7.61.
• Revenue Guidance for 2026: Increased to $5.81 billion - $5.86 billion, up from $5.77 billion - $5.84 billion.
• Growth Confidence: Strong Q1 performance and ongoing acquisitions support a positive outlook, with expectations for continued execution and integration of new operations.

4. Bad News, Challenges, or Points of Concern

• Managed Care Volatility: Concerns about potential slowdowns in skilled nursing demand due to increased clinical reviews and scrutiny were addressed, with management asserting that they do not see a broad-based decline in admissions.
• Acquisition Impact on EPS: Some analysts expressed concerns that recent acquisitions may not contribute to earnings at the same rate as existing operations, potentially indicating a softer organic growth outlook.
• Seasonality: Anticipated seasonal declines in skilled mix and occupancy during Q2 and Q3, which could impact financial performance.

5. Notable Q&A Insights

• Clinical Review Trends: Management downplayed concerns about increased clinical review intensity, stating that their experience shows it refines rather than reduces demand.
• Acquisition Strategy: Emphasis on a decentralized approach to integrating larger acquisitions, breaking them into manageable clusters for better operational control.
• Behavioral Health Opportunities: Continued interest in expanding behavioral health services, with ongoing pilot programs to assess viability in various markets.
• Labor Management Success: Enhanced visibility and data sharing have improved labor metrics, including reduced turnover and agency reliance.

Overall, Ensign Group reported strong financial performance in Q1 2026, driven by high occupancy rates, effective management of skilled nursing facilities, and a robust acquisition strategy. While there are challenges related to managed care scrutiny and seasonal fluctuations, the company remains confident in its growth trajectory and operational excellence.